Return On Equity of Keenova Therapeutics plc from 28 Mar 2014 to 26 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Keenova Therapeutics plc quarterly and annual Return On Equity in % history and change rate from 28 Mar 2014 to 26 Sep 2025.
  • Keenova Therapeutics plc Return On Equity for the quarter ending 26 Sep 2025 was 15%.
  • Keenova Therapeutics plc annual Return On Equity for 2024 was 40%.
  • Keenova Therapeutics plc annual Return On Equity for 2021 was -116%, a 55% decline from 2020.
  • Keenova Therapeutics plc annual Return On Equity for 2020 was -75%, a 109% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Keenova Therapeutics plc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 15% +31% 28 Jun 2025 26 Sep 2025
Q2 2025 38% +378% 29 Mar 2025 27 Jun 2025
Q1 2025 39% +618% 28 Dec 2024 28 Mar 2025
Q4 2024 40% +174% 28 Sep 2024 27 Dec 2024
Q3 2024 -16% 29 Jun 2024 27 Sep 2024
Q2 2024 -340% 30 Mar 2024 28 Jun 2024
Q1 2024 -579% 30 Dec 2023 29 Mar 2024
Q4 2023 -135% 15 Nov 2023 29 Dec 2023
Q3 2022 -60% +24% +28% 02 Jul 2022 30 Sep 2022
Q2 2022 -25% -2.7% -12% 17 Jun 2022 01 Jul 2022
Q1 2022 -154% -51% -50% 01 Jan 2022 01 Apr 2022
Q4 2021 -116% -41% -55% 25 Sep 2021 31 Dec 2021
Q3 2021 -84% +47% +36% 26 Jun 2021 24 Sep 2021
Q2 2021 -22% +87% +80% 27 Mar 2021 25 Jun 2021
Q1 2021 -103% -55% -114% 26 Dec 2020 26 Mar 2021
Q4 2020 -75% -39% -109% 26 Sep 2020 25 Dec 2020
Q3 2020 -131% -13% -11% 27 Jun 2020 25 Sep 2020
Q2 2020 -109% -20% -23% 28 Mar 2020 26 Jun 2020
Q1 2020 -48% +24% +33% 28 Dec 2019 27 Mar 2020
Q4 2019 -36% +29% +44% 28 Sep 2019 27 Dec 2019
Q3 2019 -118% -144% -546% 29 Jun 2019 27 Sep 2019
Q2 2019 -88% -115% -424% 30 Mar 2019 28 Jun 2019
Q1 2019 -72% -102% -344% 29 Dec 2018 29 Mar 2019
Q4 2018 -64% -103% -265% 29 Sep 2018 28 Dec 2018
Q3 2018 26% +19% +260% 30 Jun 2018 28 Sep 2018
Q2 2018 27% +19% +228% 31 Mar 2018 29 Jun 2018
Q1 2018 30% +19% +172% 30 Dec 2017 30 Mar 2018
Q4 2017 39% +34% +619% 30 Sep 2017 29 Dec 2017
Q3 2017 7.3% -5.1% -41% 01 Jul 2017 29 Sep 2017
Q2 2017 8.3% -3.3% -29% 01 Apr 2017 30 Jun 2017
Q1 2017 11% +2% +23% 31 Dec 2016 31 Mar 2017
Q4 2016 5.4% -3% -36% 01 Oct 2016 30 Dec 2016
Q3 2016 12% +6.2% +99% 25 Jun 2016 30 Sep 2016
Q2 2016 12% +14% 26 Mar 2016 24 Jun 2016
Q1 2016 8.8% +13% 26 Dec 2015 25 Mar 2016
Q4 2015 8.4% +17% 26 Sep 2015 25 Dec 2015
Q3 2015 6.2% +21% 27 Jun 2015 25 Sep 2015
Q2 2015 -2% -7.1% -139% 28 Mar 2015 26 Jun 2015
Q1 2015 -4.5% -9.4% -190% 27 Dec 2014 27 Mar 2015
Q4 2014 -8.6% 27 Sep 2014 26 Dec 2014
Q3 2014 -14% 28 Jun 2014 26 Sep 2014
Q2 2014 5.1% 29 Mar 2014 27 Jun 2014
Q1 2014 5% 28 Dec 2013 28 Mar 2014

Keenova Therapeutics plc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 40% 30 Dec 2023 27 Dec 2024
2021 -116% -41% -55% 26 Dec 2020 31 Dec 2021
2020 -75% -39% -109% 28 Dec 2019 25 Dec 2020
2019 -36% +29% +44% 29 Dec 2018 27 Dec 2019
2018 -64% -103% -265% 30 Dec 2017 28 Dec 2018
2017 39% +27% +215% 31 Dec 2016 29 Dec 2017
2016 12% +6.2% +99% 26 Sep 2015 30 Sep 2016
2015 6.2% +21% 27 Sep 2014 25 Sep 2015
2014 -14% 28 Sep 2013 26 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.